Companies
- Companies
- Company details
ESBATech
Drug DiscoveryThe company in detail
Summary
Founded in 1998, ESBATech is a privately owned spin-off biotechnology company that originated from the University of Zurich, Switzerland. ESBATech is focused on developing its therapeutic applications of its proprietary fully human antibody fragments. The company is aiming to become one of the leading companies in human antibody fragments for therapeutic applications.
Partnerships
To view this information, you must subscribe to Pharmalicensing Intelligence.
Deals
To view this information, you must subscribe to Pharmalicensing Intelligence.
Senior management
To view this information, you must subscribe to Pharmalicensing Intelligence.
Board of directors
To view this information, you must subscribe to Pharmalicensing Intelligence.
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 49 pages - $600
Jul 2010 - 24 pages - $750
Jan 2011 - 64 pages - $1,000
Dec 2010 - 64 pages - $1,000
Oct 2011 - 101 pages - $1,000
Sep 2011 - 91 pages - $1,000
Aug 2011 - 81 pages - $500
Nov 2011 - 185 pages - $2,664
Dec 2010 - 83 pages - $500
Contact details
To view this information, you must subscribe to Pharmalicensing Intelligence.
Head office
Related companies
Related categories
- Industry sector
- Biotechnology / Assay systems
- Biotechnology / Human therapeutics
- Drug discovery
- Drug discovery / High throughput screening
- Therapeutic target
- Central Nervous System
- Central Nervous System / Neurodegenerative disorders / Alzheimer's disease
- Musculoskeletal / Muscular / Inflammation
- Oncology
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us